CIK 0001022079 · Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161387862
- Phone
- 9735202700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,730,307
- in 5 filings, $16.7M under 10b5-1 plans
Net −$16,730,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
- PFEIFFER GARY M −$292K Director sold 4% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-21 | Gregg Vicky B Director | Other acquisition | +76 | $149.37 | $11K | 18,045 |
| 2024-10-21 | DELANEY MARK E SVP & Chief Commercial Officer | Other acquisition | +4 | $149.39 | $598 | 5,023 |
| 2024-10-21 | SAMAD SAM Executive Vice President & CFO | Other acquisition | +37 | $149.37 | $6K | 17,504 |
| 2024-10-21 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Other acquisition | +21 | $149.37 | $3K | 11,509 |
| 2024-10-21 | Plewman Patrick SVP for Diagnostic Services | Other acquisition | +60 | $149.37 | $9K | 16,258 |
| 2024-10-01 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +275 | 15,720.89 | ||
| 2024-09-24 | GARDNER MARK A SVP of Molecular Gen & Oncol | Shares withheld for taxes | −120 | $155.70 | $19K | 4,673 |
| 2024-08-29 | PREVOZNIK MICHAEL E SVP & General Counsel | Option exercise | +32,551 | $95.80 | $3.1M | 71,029 |
| 2024-08-29 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −32,551 | $154.97 | $5.0M | 38,478 |
| 2024-08-29 | PREVOZNIK MICHAEL E SVP & General Counsel | Option exercise · Non-Qualifed Stock Option (right to buy) | −32,551 | $95.80 | $3.1M | 0 |
| 2024-08-28 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Sale | −1,990 | $153.26 | $305K | 11,459 |
| 2024-08-14 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Shares withheld for taxes | −74 | $149.46 | $11K | 13,449 |
| 2024-07-24 | DELANEY MARK E SVP & Chief Commercial Officer | Sale | −420 | $143.08 | $60K | 5,019 |
| 2024-07-22 | DELANEY MARK E SVP & Chief Commercial Officer | Other acquisition | +6 | $146.98 | $882 | 5,439 |
| 2024-07-22 | SAMAD SAM Executive Vice President & CFO | Other acquisition | +21 | $146.97 | $3K | 17,467 |
| 2024-07-22 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Other acquisition | +31 | $146.97 | $5K | 13,511 |
| 2024-07-22 | Plewman Patrick SVP for Diagnostic Services | Other acquisition | +60 | $146.97 | $9K | 16,162 |
| 2024-07-22 | Gregg Vicky B Director | Other acquisition | +77 | $146.97 | $11K | 17,969 |
| 2024-07-16 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −3,910 | $142.65 | $558K | 17,446 |
| 2024-07-01 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +308 | 15,367.45 |
Page 18 of 21 · 409 trades